Despite some limitations in its formation due to myrosinase enzyme activity as well as gut microbiota metabolism, in vivo studies have demonstrated how SFN reduces inflammatory markers and attenuate lipid peroxidation and oxidative stress in patients suffering from diabetes, improving fasting blood glucose levels and stabilizing insulin response (60, 66). Here, INS is linked to diabetes mellitus.